CaryHealth Wins 2025 AI TechAward for Excellence in AI Healthcare Innovation 
Somite AI Announces Series A Led by Khosla Ventures to Revolutionize Cell Therapy with AI Foundation Models
BOSTON, May 13, 2025 /PRNewswire/ -- Somite AI, a TechBio company leveraging foundation models and proprietary AI to accelerate human...
H3PT Announces 2025 Council Members, Elevating Healthcare Security and Third-Party Risk Management Standards Amid HIPAA Security 2.0 Advancements
ATLANTA, May 13, 2025 /PRNewswire/ -- The Health 3rd Party Trust Initiative (H3PT) proudly announces the selection of its 2025...
Hearing Wellness Pioneer Eargo Launches Eargo 8 As Its Newest Flagship Hearing Aid
Eargo 8 redefines the over-the-counter hearing aid experience to help people hear life to the fullest. SAN JOSE, Calif., May...
Homecare Homebase Earns HIPAA Milestone for De-identification of PHI, Supporting Planned AI Innovations
Evaluation confirms HCHB's de-identification methodology meets HIPAA standards for data privacy, supporting secure, scalable AI development that serves clinicians and...
PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients
With a Growing List of 30+ Global Customers, Including Top Pharma, PhaseV is Poised to Transform Clinical Development at Scale...
CliniComp Earns Recognition for EHR Innovation in 2025 MedTech Breakthrough Awards Program
EHR leader honored for second consecutive year among trailblazers in digital health and medical technology industry SAN DIEGO, May 13,...
Serotonin Centers Announces Landmark Southeast Florida Area Development
Leading National Anti-Aging Med Spa Franchise Signs Multi-Unit Agreement for 18 New Locations in the South Florida Region Serotonin Centers...
Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 – – On track to...
General Oncology to Participate in Three Upcoming Conferences
BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for...
Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer
— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular...
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
See how innovation is transforming patient outcomes through real-world clinical insights and patient storiesVALENCIA, Calif., May 13, 2025 (GLOBE NEWSWIRE) --...
Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market
BEIJING, May 13, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic...
Visory Health Expands Veteran Support Through New Partnership with Hope for the Warriors
The new partnership introduces healthcare resources for Veterans and military families, helping reduce out-of-pocket medication costsESTERO, Fla., May 13, 2025...
Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform
Evidence-based lifestyle modification platform for oncology achieves 90%+ adherence with new dedicated CoActive Coach model, significantly improving cancer-related health outcomes.NEW...
Doheny Eye Institute Announces Kaustabh Ghosh, Ph.D. as the Mary D. Allen Endowed Chair in Vision Research
Dr. Ghosh is an interdisciplinary vision researcher with an interest in investigating the mechanisms underlying early diabetic retinopathy and age-related...
HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization
Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells...
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
Survival observations in mTNBC patients correlated with increased PD-L1 expression Preliminary evidence suggests leronlimab has potential to turn “cold” tumors...
Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study
Milestone Achieved as Adovate Initiates First-in-Human Study for Novel Asthma Therapy Targeting Underserved, Multi-Billion Dollar MarketGlen Allen, Va., May 13,...
Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis...
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting
Advancements Lay the Groundwork for Future Genetic Medicines for Rare and Prevalent Forms of Heart DiseaseSOUTH SAN FRANCISCO, Calif., May...